A case report of fatal familial insomnia with cerebrospinal fluid leukocytosis during the COVID-19 epidemic and review of the literature
2024

Fatal Familial Insomnia Case Report During COVID-19

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Wang Zheng, Huang Yueqi, Wang Shuqi, Chen Jiefang, Meiduo Gesang, Jin Man, Zhang Xiaoying

Primary Institution: Affiliated Mental Health Center & Hangzhou Seventh People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China

Hypothesis

Can elevated white blood cells in cerebrospinal fluid indicate fatal familial insomnia (FFI) during the COVID-19 pandemic?

Conclusion

The case suggests that FFI patients may exhibit elevated white blood cells in cerebrospinal fluid, and timely detection of Tau protein is crucial for early identification.

Supporting Evidence

  • The patient exhibited psychobehavioral abnormalities and cognitive decline.
  • Elevated white blood cell count in cerebrospinal fluid was noted.
  • Genetic testing confirmed the diagnosis of FFI.

Takeaway

A young man with sleep problems and memory loss was found to have a rare disease called fatal familial insomnia, which can show unusual signs like high white blood cell counts in his spinal fluid.

Methodology

The patient underwent lumbar punctures, MRI, EEG, and genetic testing to diagnose FFI.

Limitations

The patient's family refused an autopsy for histopathological confirmation.

Participant Demographics

A 28-year-old male courier with no positive family history of similar diseases.

Digital Object Identifier (DOI)

10.1080/19336896.2023.2298520

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication